Oncology division

Quote
anonymous said:
How can it be “ending” when we have two FDA approved indications with them? Do you mean Merck will stop promoting the Lenvima combos on their end?
Click to expand...
Promotional efforts are halting. Also, a restructuring of the 'ownership contract' based on Eisai/Len not hitting set forth milestones. This is why Merck was able to, legally, partner with another company's TKI. Merck knows they have the wrong companion TKI and are cutting bait.
 






anonymous said:
Promotional efforts are halting. Also, a restructuring of the 'ownership contract' based on Eisai/Len not hitting set forth milestones. This is why Merck was able to, legally, partner with another company's TKI. Merck knows they have the wrong companion TKI and are cutting bait.
Click to expand...
Eisai not living up to expectactions? Say it ain’t so!
 


































































anonymous said:
Like, that’s “what they get for Pearl Harbor” ??
That’s what grandpa always said
Click to expand...
and then some...perhaps you should research Japan and it's occupation and dealings of other Asian countries throughout history.

Pearl Harbor is merely one of the many atrocities committed by the Japanese...so yeah, they got what they had coming.
 






anonymous said:
and then some...perhaps you should research Japan and it's occupation and dealings of other Asian countries throughout history.

Pearl Harbor is merely one of the many atrocities committed by the Japanese...so yeah, they got what they had coming.
Click to expand...
Yep. Bataan, Nanjing, Manchuria, Korea, etc. Lots of blood on their hands.
 










































Top Bottom
Back
Quote